Continuing its aim of helping Americans through the COVID-19 pandemic, the FDA has relaxed certain requirements for veterinarians that should promote increased utilization of telemedicine.
It has temporarily suspended its enforcement of
the requirement that vets must physically examine the animal and/or make
medically appropriate and timely visits to the location where the
animal is kept. This will allow the prescribing of drugs without a
direct exam.
Vet-related tickers: Elanco Animal Health (ELAN +6.5%), Zoetis (ZTS +10.7%), PetIQ (PETQ +9.6%), PetMed Express (PETS +3.2%), Bayer (OTCPK:BAYRY +5.8%), Merck (MRK +3.8%)
https://seekingalpha.com/news/3554743-fda-backs-telemedicine-for-vets
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.